Statistics
Publications
4
Citations
1.1K
H-Index
4
Active since
1988
Affiliations
Pfizer (United States)(Current)
Craig R. Kent is an author at Pfizer (United States) specializing in jak-stat signaling pathway, jak inhibitors, and pharmacology.
Publications per year
1988–2010
4
4
Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor
Paul S. Changelian, Mark E. Flanagan, Douglas J. Ball et al. · Science · 2003 · 670 citations · Full text
Medicine, Immunology, Pharmacology +17
Mark E. Flanagan, Todd A. Blumenkopf, William H. Brissette et al. · Journal of Medicinal Chemistry · 2010 · 335 citations · Full text
The specificity of JAK3 kinase inhibitors
Paul S. Changelian, Deborah Moshinsky, Cyrille Kuhn et al. · Blood · 2007 · 95 citations · Full text
Donald R. Hahn, Richard S. Myers, Craig R. Kent et al. · Molecular and General Genetics MGG · 1988 · 39 citations
1–4 of 4